![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/17/2914415/0/en/CytoMed-Therapeutics-Acquires-Cord-Blood-Banking-Licence-and-Assets-to-Entrench-Its-Strategy-in-Allogeneic-Off-the-shelf-Donor-derived-Gamma-Delta-%CE%B3%CE%B4-T-Cells-Technology-for-Solid-a.html
https://www.globenewswire.com/news-release/2024/03/18/2847610/0/en/CytoMed-Therapeutics-to-Launch-Complimentary-Cell-Banking-for-Qualified-Shareholders-for-Future-Precision-Therapies.html
https://www.globenewswire.com//news-release/2024/03/04/2839299/0/en/CytoMed-Therapeutics-Limited-Announces-Research-Collaboration-with-Singapore-Sengkang-General-Hospital-to-Advance-Injectable-Umbilical-Cord-Derived-Mesenchymal-Stem-Cells-for-Carti.html
https://www.globenewswire.com/news-release/2024/01/29/2818731/0/en/Malaysian-Patent-Granted-for-CytoMed-Therapeutics-Licensed-Allogeneic-CAR-Gamma-Delta-T-Cell-Technology.html
https://www.prnewswire.com/news-releases/cytomed-therapeutics-signs-hoa-and-mou-to-advance-research-on-allogeneic-gamma-delta-t-cell-technology-302005975.html
https://www.prnewswire.com/news-releases/cytomed-therapeutics-reports-first-half-2023-financial-report-and-provides-corporate-update-301992191.html
https://www.prnewswire.com/news-releases/cytomed-therapeutics-to-present-at-the-benchmark-companys-upcoming-discovery-one-on-one-investor-conference-301987519.html
https://www.prnewswire.com/news-releases/chinese-patent-granted-for-cytomed-therapeutics-licensed-ipsc-based-technology-301936668.html
https://www.biospectrumasia.com/news/26/22424/singapores-cytomed-therapeutics-announces-collaboration-with-md-anderson-cancer-center-in-us.html
https://www.prnewswire.com/news-releases/cytomed-therapeutics-limited-announces-collaboration-with-md-anderson-cancer-center-to-advance-allogeneic-off-the-shelf-gamma-delta-t-cells-in-oncology-301819685.html